Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway

Abstract

C-Abl is a nonreceptor tyrosine kinase that is tightly regulated in the cell. Genetic data derived from studies in flies and mice strongly support a role for Abl kinases in the regulation of the cytoskeleton (reviewed in [1,2]). C-Abl can be activated by several stimuli, including oxidative stress [3], DNA damage [4], integrin engagement [5], growth factors, and Src family kinases [6]. Structural alterations elicit constitutive activation of the c-Abl tyrosine kinase, leading to oncogenic transformation. While the mechanisms that activate c-Abl are beginning to be elucidated, little is known regarding the mechanisms that downregulate activated c-Abl. Here, we show for the first time that activated c-Abl is downregulated by the ubiquitin-dependent degradation pathway. Activated forms of c-Abl are more unstable than wild-type and kinase-inactive forms. Moreover, inhibition of the 26S proteasome leads to increased c-Abl levels in vitro and in cells, and activated c-Abl proteins are ubiquitinated in vivo. Significantly, inhibition of the 26S proteasome in fibroblasts increases the levels of tyrosine-phosphorylated, endogenous c-Abl. Our data suggest a novel mechanism for irreversible downregulation of activated c-Abl, which is critical to prevent the deleterious consequences of c-Abl hyperactivation in mitogenic and cytoskeletal pathways.

DOI: 10.1016/S0960-9822(01)00538-3

Extracted Key Phrases

4 Figures and Tables

Statistics

050100'03'05'07'09'11'13'15'17
Citations per Year

191 Citations

Semantic Scholar estimates that this publication has 191 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Echarri2001ActivatedCI, title={Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway}, author={Asier Echarri and Ann Marie Pendergast}, journal={Current Biology}, year={2001}, volume={11}, pages={1759-1765} }